Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors
- 1 January 1991
- journal article
- Published by Elsevier in Neuroscience
- Vol. 40 (1) , 169-174
- https://doi.org/10.1016/0306-4522(91)90182-n
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Potential use of drugs modulating 5HT activity in the treatment of anxietyGeneral Pharmacology: The Vascular System, 1988
- The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonistBritish Journal of Pharmacology, 1988
- Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleusEuropean Journal of Pharmacology, 1988
- Reticular elicitation of hippocampal slow waves: Common effects of some anxiolytic drugsNeuroscience, 1986
- Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drugEuropean Journal of Pharmacology, 1986
- BuspironeDrugs, 1986
- Dopaminergic effects of buspirone, a novel anxiolytic agentBiochemical Pharmacology, 1983
- Comparative neuropharmacology of antianxiety drugsPharmacology Biochemistry and Behavior, 1982
- Reticular stimulation and hippocampal theta rhythm in rats: Effects of drugsNeuroscience, 1978
- Septal driving of hippocampal theta rhythm as a function of frequency in the free-moving male ratNeuroscience, 1977